The company's portfolio includes various types of nanotechnology delivery systems, based on lipid and polymer delivery systems or a combination of these constituents. Additionally, the company has a dedicated development segment for the design and synthesis of biomimetic peptides. These peptides represent a cutting-edge innovation in the cosmetic industry as active ingredients for cosmetic formulations. In 2022, the company filed five patents and received INCI names for two proprietary peptides, solidifying its position as a leading player in this field.
Interestingly, Glia Innovation's team has successfully merged the fields of nanotechnology and peptide design, resulting in the creation of bio-guided polymeric nanoparticles that are propelled by the peptides present on the surface of these carriers. With a focus on high-impact, high-performance, and high-value-added solutions, Glia Innovation has established itself as a standout player in the cosmetic market.
As a recognition of our differentiation and disruption, Glia Innovation recently participated in In Cosmetic Global 2023, where it was recognized as one of the ten finalist companies for the Rising Stars Innovation Award out of 257 participating companies. This recognition reflects the company's commitment to being at the forefront of technology and the development of new products and services for the cosmetic market.
Glia Innovation continues to evolve and research constantly, always seeking to offer innovative and high-performance solutions to its customers while enhancing the development of advanced technologies for the cosmetic market.
